Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. 2012

Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
Department of Infectious Diseases, Central Hospital, Kristianstad, Sweden. rolf.alsterlund@skane.se

In 2009 we described an outbreak caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in southern Sweden that occurred during 2005-2006. An important finding from the investigation was the long carriage times of the ESBL-producing E. coli in several of the patients, which in some cases exceeded 30 months. Here we report findings from the continued follow-up of bacterial carriage. In September 2010, 5 of the 42 patients still carried the bacteria after a median of 58 months (range 41-59 months), 18 had had repeatedly negative cultures after shedding bacteria for a median of 7.5 months (range 0-39 months), 16 had died while still shedding the bacteria for a median of 9 months (range 0-38 months), and 3 had been lost to follow-up.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
December 2013, Journal of chemotherapy (Florence, Italy),
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
June 2022, Journal of Nepal Health Research Council,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
March 2017, Postepy higieny i medycyny doswiadczalnej (Online),
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
November 2008, The Journal of antimicrobial chemotherapy,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
January 2020, IDCases,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
April 2020, Applied and environmental microbiology,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
April 2020, The Lancet. Infectious diseases,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
April 2020, The Lancet. Infectious diseases,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
February 2017, Turkish journal of medical sciences,
Rolf Alsterlund, and Carolina Axelsson, and Barbro Olsson-Liljequist
September 2008, Archives of internal medicine,
Copied contents to your clipboard!